Nestlé India faces three FSSAI cases over infant-food claims and biotin compliance
India’s food regulator has initiated three adjudication cases against Nestlé India concerning prohibited promotional claims for infant nutrition products and non-compliant biotin content. The action signals tighter scrutiny of food advertising, labelling and infant-food standards.
What happened
FSSAI initiated three adjudication cases against Nestlé India over prohibited promotional claims for infant nutrition products and non-compliant biotin content.
Key facts
- 3 separate adjudication cases
- More than 150 FSSAI notices issued to food companies in recent months
- 2-phase proposed front-of-pack labelling system
What changed
FSSAI initiated three adjudication cases against Nestlé India over prohibited promotional claims for infant nutrition products and non-compliant biotin content. The action highlights intensified Indian enforcement on food advertising, labelling and infant-food standards.
Why this matters
Nestlé India’s FSSAI cases raise immediate compliance pressure on infant-nutrition claims, labelling and formulation controls, making a rapid portfolio-wide audit essential.
What to watch
- FSSAI adjudication orders, penalty amounts, corrective-action requirements or recall directions.
- Any FSSAI circular expanding enforcement on infant-food advertising, nutrient fortification or online product listings.
- New notices involving other infant-nutrition, pediatric nutrition, fortified-food or health-supplement companies.
- Changes in Nestlé India disclosures on legal proceedings, provisions, product reformulation or marketing restrictions.
- Retailer and marketplace requests for updated labels, lab reports, certificates or claim substantiation.